Navigating the Competitive Terrain of Weight-Loss Pharmaceuticals

This chapter explores Viking Therapeutics' challenges in the competitive landscape of weight-loss drugs, particularly against giants like Eli Lilly and Novo Nordisk. It examines concerns about Viking's drug tolerability and its trial data, questioning consumer preferences and market reactions.